冠状神经血管膜与检查点抑制剂患者的乳头炎相关
Tian Xia1,2, Peter Bracha2,3, Nirali Bhatt2
1Retina Vitreous Consultants, Livingston, New Jersey.
Retinal cases & brief reports
|August 29, 2023
概括
这份病例报告详细介绍了一名患有肺癌的患者,由于乳头炎和与 pembrolizumab 相关的胸腔神经血管膜导致视力丧失. 用抗VEGF疗法治疗成功解决了这些眼部并发症.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 布罗利祖马布是一种免疫检查点抑制剂,用于高级肺癌.
- 眼部不良反应是已知 pembrolizumab 治疗的并发症.
- 周 papillary 冠状腺新血管膜 (CNVM) 是一种罕见但严重的眼睛疾病.
相关概念视频
Open Angle Glaucoma: Treatment
477
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
477
Angle Closure Glaucoma: Treatment
560
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
560


